Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e447
JournalThe Lancet Haematology
Volume6
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Morbid Obesity
Factor Xa Inhibitors

ASJC Scopus subject areas

  • Hematology

Cite this

Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply. / Kushnir, Margarita.

In: The Lancet Haematology, Vol. 6, No. 9, 01.09.2019, p. e447.

Research output: Contribution to journalLetter

@article{4cebe6655ef14b028b8385821cbc54da,
title = "Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply",
author = "Margarita Kushnir",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/S2352-3026(19)30171-1",
language = "English (US)",
volume = "6",
pages = "e447",
journal = "The Lancet Haematology",
issn = "2352-3026",
publisher = "Lancet Publishing Group",
number = "9",

}

TY - JOUR

T1 - Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

AU - Kushnir, Margarita

PY - 2019/9/1

Y1 - 2019/9/1

UR - http://www.scopus.com/inward/record.url?scp=85071243401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071243401&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(19)30171-1

DO - 10.1016/S2352-3026(19)30171-1

M3 - Letter

C2 - 31471007

AN - SCOPUS:85071243401

VL - 6

SP - e447

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 9

ER -